Melperone: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
== Melperone == | |||
<gallery> | |||
File:Melperone.svg|Melperone | |||
File:Melperone 3D ball.png|Melperone | |||
File:Melperone synthesis.svg|Melperone | |||
</gallery> | |||
Latest revision as of 01:42, 20 February 2025
Melperone is an atypical antipsychotic and sedative that is used in the treatment of schizophrenia and other psychotic disorders. It is also used as a sleep aid due to its sedative properties. Melperone is marketed under the brand name Buronil.
Etymology[edit]
The term "Melperone" is derived from the chemical name of the drug, which is 4'-((2-methyl-1-propyl)-3-piperidyl)-2-benzyl-1,1-diphenylbutylone.
Pharmacology[edit]
Melperone acts as an antagonist at various dopamine, serotonin, and adrenergic receptors. It has a high affinity for the D2, 5-HT2A, 5-HT2C, and α1-adrenergic receptors, and a moderate affinity for the D1, D3, D4, 5-HT1A, 5-HT6, and α2-adrenergic receptors.
Medical uses[edit]
Melperone is used in the treatment of various psychiatric disorders including schizophrenia, acute and chronic psychosis, and agitated states. It is also used as a sleep aid due to its sedative properties.
Side effects[edit]
Common side effects of Melperone include drowsiness, dizziness, dry mouth, and weight gain. Less common side effects include extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome.
History[edit]
Melperone was first synthesized in the 1960s by the German pharmaceutical company Hoechst AG. It was first marketed in Europe in the 1970s under the brand name Buronil.
